| |
Pre-HIIT
|
Post-HIIT
|
95% CI (lower, upper)
|
p Value
|
Effect size (d)
|
|---|
|
Systemic inflammation
|
|
IL-1β, pg/ml
|
0.12 ± 0.13
|
0.12 ± 0.11
|
(− 0.04, 0.06)
|
0.788
|
0.07
|
|
IL-6, pg/ml
|
1.06 ± 0.89
|
1.43 ± 2.02
|
(− 1.6, 0.8)
|
0.519
|
0.19
|
|
CXCL-8, pg/ml
|
9.69 ± 6.97
|
10.3 ± 10.0
|
(− 3.3, 2.2)
|
0.655
|
0.13
|
|
IL-10, pg/ml
|
0.5 ± 0.4
|
0.5 ± 0.3
|
(− 0.1, 0.1)
|
0.912
|
0.03
|
|
TNF-α, pg/ml
|
2.21 ± 0.96
|
2.31 ± 0.96
|
(− 0.5, 0.3)
|
0.570
|
0.17
|
|
White blood cells, ×106/L
|
|
Total count
|
5.6 ± 1.1
|
5.8 ± 1.2
|
(− 0.6, 0.2)
|
0.322
|
0.32
|
|
Neutrophils
|
2.8 ± 0.8
|
2.9 ± 0.9
|
(− 0.5, 0.1)
|
0.217
|
0.40
|
|
Lymphocytes
|
2.0 ± 0.6
|
2.1 ± 0.6
|
(− 0.4, 0.2)
|
0.623
|
0.15
|
|
Monocytes
|
0.6 ± 0.2
|
0.6 ± 0.2
|
(− 0.1, 0.1)
|
0.676
|
0.12
|
|
Eosinophils
|
0.3 ± 0.3
|
0.2 ± 0.1
|
(− 0.02, 0.2)
|
0.108
|
0.53
|
|
Neutrophils: lymphocytes
|
1.5 ± 0.6
|
1.5 ± 0.5
|
(− 0.4, 0.3)
|
0.810
|
0.07
|
|
Glucose, insulin, and NEFA
|
|
Fasting glucose (mg/dl)
|
90.9 ± 7.7
|
93.1 ± 8.3
|
(− 4.8, 0.5)
|
0.098
|
0.55
|
|
Fasting insulin, μIU/ml
|
13 ± 4.9
|
12 ± 4.8
|
(− 0.8, 2.7)
|
0.264
|
0.34
|
|
HOMA-IR
|
1.67 ± 0.64
|
1.56 ± 0.62
|
(− 0.1, 0.3)
|
0.258
|
0.34
|
|
NEFA, mmol/L
|
0.55 ± 0.37
|
0.60 ± 0.36
|
(− 0.2, 0.1)
|
0.412
|
0.24
|
- Abbreviations: HIIT High-intensity interval training, IL Interleukin, CXCL Chemokine C-X-C motif ligand, TNF-α Tumor necrosis factor-α, HOMA-IR Homeostatic model of assessment of insulin resistance, NEFA Nonesterified fatty acids
- Data are mean ± SD
